Literature DB >> 31159571

The Intensity of Hospital Care Utilization by Dutch Patients With Lung or Colorectal Cancer in their Final Months of Life.

Yvonne de Man1, Femke Atsma1, Mariska G Oosterveld-Vlug2, Linda Brom3, Bregje D Onwuteaka-Philipsen2, Gert P Westert1, A Stef Groenewoud1.   

Abstract

Understanding the overuse and underuse of health-care services in the end-of-life (EoL) phase for patients with lung cancer (LC) and colorectal cancer (CRC) is important, but knowledge is limited. To help identify inappropriate care, we present the health-care utilization profiles for hospital care at the EoL of patients with LC (N = 25 553) and CRC (N = 14 911) in the Netherlands between 2013 and 2015. An administrative database containing all in-hospital health-care activities was analyzed to investigate the association between the number of days patients spent in the emergency department (ED) or intensive care unit (ICU) and their exposure to chemotherapy or radiotherapy. Fewer patients received hospital care as death neared, but their intensity of care increased. In the last month of life, the average numbers of hospital bed days, ICU days, and ER contacts were 9.0, 5.5, and 1.2 for patients with CRC, and 8.9, 6.2 and 1.2 for patients with LC in 2015. On the other hand, the occurrence of palliative consultations ranged from 1% to 4%. Patients receiving chemotherapy 6 months before death spent fewer days in ICU than those who did not receive this treatment (odds ratios: CRC = 0.6 [95% confidence interval: 0.4-0.8] and LC = 0.7 [0.5-0.9]), while those receiving chemotherapy 1 month before death had more ED visits (odds ratios: CRC = 17.2 [11.8-25.0] and LC = 15.8 [12.0-20.9]). Our results showed that patients who were still receiving hospital care when death was near had a high intensity of care, yet palliative consultations were low. Receiving chemotherapy or radiotherapy in the final month of life was significantly associated with more ED and ICU contacts in patients with LC.

Entities:  

Keywords:  colorectal cancer; end-of-life; hospital care; lung cancer; overtreatment; undertreatment

Mesh:

Year:  2019        PMID: 31159571      PMCID: PMC6552371          DOI: 10.1177/1073274819846574

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  4 in total

1.  The use of in-hospital medical care for patients with metastasized colon, bronchus, or lung cancer.

Authors:  Isabeau S L van Brakel; Martijn M Stuiver; Sjoerd M Euser; Gerty J de Klerk; Karlijn J van Stralen
Journal:  Support Care Cancer       Date:  2021-04-30       Impact factor: 3.603

2.  Care trajectories of chronically ill older adult patients discharged from hospital: a quantitative cross-sectional study using health insurance claims data.

Authors:  Yvonne de Man; Femke Atsma; Wilma Jonkers; Sophia E J A de Rooij; Gert P Westert; Patrick P T Jeurissen; A Stef Groenewoud
Journal:  BMC Geriatr       Date:  2019-10-15       Impact factor: 3.921

3.  Identified GNGT1 and NMU as Combined Diagnosis Biomarker of Non-Small-Cell Lung Cancer Utilizing Bioinformatics and Logistic Regression.

Authors:  Jia-Jia Zhang; Jiang Hong; Yu-Shui Ma; Yi Shi; Dan-Dan Zhang; Xiao-Li Yang; Cheng-You Jia; Yu-Zhen Yin; Geng-Xi Jiang; Da Fu; Fei Yu
Journal:  Dis Markers       Date:  2021-01-06       Impact factor: 3.434

4.  Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases.

Authors:  Annemarie C Eggen; Geke A P Hospers; Ingeborg Bosma; Miranda C A Kramer; Anna K L Reyners; Mathilde Jalving
Journal:  BMC Cancer       Date:  2022-03-05       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.